NasdaqCM - Delayed Quote USD
eXoZymes, Inc. (EXOZ)
13.53
+1.74
+(14.76%)
At close: April 23 at 4:00:01 PM EDT
13.53
0.00
(0.00%)
After hours: April 23 at 4:05:07 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Michael Heltzen | President & CEO | 271.25k | -- | 1981 |
| Dr. Tyler Korman Ph.D. | Co-Founder & Vice President of Research | 245.67k | -- | 1979 |
| Dr. Paul Opgenorth Ph.D. | Co-Founder & Vice President of Development | 242.8k | -- | 1983 |
| Mr. Fouad Nawaz | Vice President of Finance | 183.75k | -- | 1986 |
| Mr. James U. Bowie Ph.D. | Founder & Independent Director | -- | -- | 1962 |
| Mr. Lasse H. Gorlitz | Vice President of Communications | -- | -- | -- |
| Mr. Michael Burns | Executive Vice President of Energy Transition | -- | -- | -- |
| Dr. Zachary Karl Ph.D. | VP & Head of Business Development | -- | -- | -- |
| Mr. Damien A. Perriman | Chief Commercial Officer | -- | -- | 1977 |
eXoZymes, Inc.
750 Royal Oaks Drive
Suite 106
Monrovia, CA 91016
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 31
Description
eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. The company was founded in 2014 and is headquartered in Monrovia, California.
Corporate Governance
eXoZymes, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 31, 2025 at 8:00 PM UTC
eXoZymes, Inc. Earnings Date
Recent Events
Related Tickers
CUE Cue Biopharma, Inc.
0.8363
+6.85%
1OT.F Ovid Therapeutics Inc.
0.1960
-5.77%
RXK3.F SELLAS Life Sciences Group, Inc.
1.1760
+8.89%
LTI0.F Aptose Biosciences Inc. R
2.0200
+1.00%
1VT.MU Viking Therapeutics Inc
22.37
+7.65%
GOVXW GeoVax Labs, Inc.
0.0300
-0.33%
APTOF Aptose Biosciences Inc.
2.3100
-6.48%
CLVLY Clinuvel Pharmaceuticals Limited
7.10
0.00%
BINV.ST BioInvent International AB (publ)
29.10
+3.19%
WHWK Whitehawk Therapeutics, Inc.
1.5400
0.00%